𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined modality therapy for limited-disease small cell lung cancer

✍ Scribed by Luis Raez; Michael Samuels; Rogerio Lilenbaum


Book ID
107531899
Publisher
Springer
Year
2005
Tongue
English
Weight
188 KB
Volume
6
Category
Article
ISSN
1527-2729

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Results of combined-modality therapy for
✍ Steven E. Schild; Philip J. Stella; Burke J. Brooks; Sumithra Mandrekar; James A πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twice‐daily radiotherapy (BIDRT) or once‐daily radiotherapy (QDRT) resulted in a better outcome for patients with limited‐st

Combined modality therapy for locally ad
✍ D. Recine; K. Rowland; S. Reddy; M. S. Lee; P. Bonomi; S. Taylor IV; L. P. Faber πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 691 KB

Multi-modality treatment consisting of cisplatin, VP-16, and 5-fluorouracil chemotherapy given concomitantly with external beam radiation was used to treat 64 patients with locally advanced Stage I11 non-small cell lung carcinoma. This regimen was used in a preoperative fashion for four cycles in pa

Combined modality therapy for stage IIIM
✍ Patricia J. Madej; Jacob D. Bitran; Harvey M. Golomb; Philip G. Hoffman Jr; Thom πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 720 KB

Between 1975 and 1980, 101 patients with inoperable Stage IIIMO non-small cell lung carcinoma were entered into combined radiotherapy and chemotherapy trials at Michael Reese Hospital and University of Chicago Hospital. Sixty-four percent of the patients responded. Median survival for all patients w